Overview

A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy

Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
A clinical outcomes study measuring reduction in pain and numbness experienced in four types of peripheral neuropathy patients during 60 day administration of the an amino acid formulation.
Phase:
Phase 2
Details
Lead Sponsor:
Targeted Medical Pharma